Nicholas Investment Partners, LP Jazz Pharmaceuticals PLC Transaction History

Nicholas Investment Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$141.59 - $168.66 $4.33 Million - $5.15 Million	30,552 New	30,552 $4.77 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $2.26 Million - $3.24 Million	-19,450 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $189,830 - $212,892	-1,179 Reduced 5.72%	19,450 $3.27 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $253,736 - $317,634	1,734 Added 9.18%	20,629 $3.55 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $208,944 - $242,183	1,541 Added 8.88%	18,895 $2.85 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $605,628 - $694,952	-4,621 Reduced 21.03%	17,354 $2.34 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $3.13 Million - $3.42 Million	21,975	21,975 $3.21 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.